Ignite Creation Date:
2025-12-25 @ 2:46 AM
Ignite Modification Date:
2026-01-06 @ 8:58 AM
Study NCT ID:
NCT01412333
Status:
COMPLETED
Last Update Posted:
2024-03-08
First Post:
2011-08-08
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis
Sponsor:
Organization: